Diferencia entre revisiones de «Sexually transmitted diseases»

 
(No se muestran 5 ediciones intermedias de 2 usuarios)
Línea 2: Línea 2:
*STD Prevalence: [[Human papillomavirus|HPV]] > [[Human papillomavirus|HSV-2]] > [[Trichomonas]] > [[Chlamydia trachomatis|Chlamydia]] > [[HIV]] > [[HBV]] > [[Neisseria gonorrhoeae|Gonorrhea]] > [[Syphilis]]
*STD Prevalence: [[Human papillomavirus|HPV]] > [[Human papillomavirus|HSV-2]] > [[Trichomonas]] > [[Chlamydia trachomatis|Chlamydia]] > [[HIV]] > [[HBV]] > [[Neisseria gonorrhoeae|Gonorrhea]] > [[Syphilis]]
*STD New infections: HPV > Chlamydia > Trichomonas > Gonorrhea > HSV-2 > Syphilis > [[HIV]] > HBV <ref>[http://www.cdc.gov/std/stats/sti-estimates-fact-sheet-feb-2013.pdf CDC: STI Fact sheet 2013]</ref>
*STD New infections: HPV > Chlamydia > Trichomonas > Gonorrhea > HSV-2 > Syphilis > [[HIV]] > HBV <ref>[http://www.cdc.gov/std/stats/sti-estimates-fact-sheet-feb-2013.pdf CDC: STI Fact sheet 2013]</ref>
*It is important to treat sexual partners for all STDs
**See [[Expedited Partner Therapy]]


==Clinical Features==
==Clinical Features==
Línea 14: Línea 12:
==Evaluation==
==Evaluation==


==Management==
==Management <ref> https://www.cdc.gov/std/treatment-guidelines/STI-Guidelines-2021.pdf </ref>==
*Consider empiric treatment for [[Gonorrhea]] and [[Chlamydia]]:
**[[Ceftriaxone]] 500 mg IM x1 (1g IM for pts > 150 kg) '''AND'''
**[[Doxycycline]] 100mg PO BID x 7 days (preferred) '''OR'''
**[[Azithromycin]] 1g PO x 1 (alternative regimen) '''OR'''
**[[Azithromycin]] 500 mg PO x 1 and 250mg PO daily x 4 days
 
*It is important to treat sexual partners for all STDs
**See [[Expedited Partner Therapy]]


==Disposition==
==Disposition==

Revisión actual - 16:16 28 jul 2022

Background

Clinical Features

STD Visual Diagnosis (Male)

STD Visual Diagnosis (Female)

Differential Diagnosis

Sexually transmitted diseases

Evaluation

Management [2]

Disposition

See Also

External Links

References